
Aducanumab and the Business of Alzheimer Disease; Implicit Light Sensitivity in Migraine
Neurology® Podcast
00:00
Is This a Drug That Should Be Dosed and to a Patient After Receiving a Prescription?
The accelerator approvel requires a further study to validate the actual relationship between lowering amaloid using this drug and clinical benefit. How that study will be done now, if the drugs out there commercially remains a conundrum. And its vant honor to interviewed r kaiser, a neuralogist otheheading specialist at the university of pennsylvania,. about his article, reflextive eye closure in response to cone and met nopson stimulation.
Transcript
Play full episode